Skip to content

Clinical trials

Thrombocythemia, Essential trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocythemia, Essential Country / region: Australia Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20132
20143
20201
20211
20232
20243
20251
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed5
Active, not recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation4
Merck Sharp & Dohme LLC3
CTI BioPharma2
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)2
Sierra Oncology LLC - a GSK company2
Damora Therapeutics1
Eilean Therapeutics AU Pty Ltd1
Jubilant Therapeutics Inc.1
Novartis Pharmaceuticals1
S*BIO1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocythemia, Essential18
Primary Myelofibrosis12
Myeloproliferative Disorders10
Polycythemia Vera8
Hematologic Diseases5
Bone Marrow Diseases4
Hemorrhagic Disorders3
Anemia2
Blood Coagulation Disorders2
Blood Platelet Disorders2

Trials

Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.